{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:18:49Z","timestamp":1791346729091,"version":"4.3.1"},"reference-count":161,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T00:00:00Z","timestamp":1635552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["19EIA34760167"],"award-info":[{"award-number":["19EIA34760167"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["21PRE830396"],"award-info":[{"award-number":["21PRE830396"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["1R01HL147639-01A1"],"award-info":[{"award-number":["1R01HL147639-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jacbts.2021.10.017","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T17:22:39Z","timestamp":1642612959000},"page":"410-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["HIV, Combination Antiretroviral Therapy, and Vascular Diseases in Men and Women"],"prefix":"10.1016","volume":"7","author":[{"given":"Laszlo","family":"Kovacs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor C.","family":"Kress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Belin de Chantem\u00e8le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacbts.2021.10.017_bib2","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacbts.2021.10.017_bib3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MCA.0000000000000450","article-title":"Acute coronary syndromes in patients with HIV","volume":"28","author":"Seecheran","year":"2017","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib4","first-page":"127","article-title":"Cardiovascular complications of HIV infection","volume":"24","author":"Glesby","year":"2017","journal-title":"Top Antivir Med"},{"key":"10.1016\/j.jacbts.2021.10.017_bib5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(18)31311-4","article-title":"HIV","volume":"392","author":"Ghosn","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jacbts.2021.10.017_bib6","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","article-title":"Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis","volume":"138","author":"Shah","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.10.017_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11904-018-0383-2","article-title":"Sex differences in HIV infection","volume":"15","author":"Scully","year":"2018","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.jacbts.2021.10.017_bib8","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1210\/jc.2006-2190","article-title":"Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease","volume":"92","author":"Triant","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jacbts.2021.10.017_bib9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/QAI.0b013e31825c7f24","article-title":"Comparison of ischemic stroke incidence in HIV-infected and non\u2013HIV-infected patients in a US health care system","volume":"60","author":"Chow","year":"2012","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacbts.2021.10.017_bib10","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1212\/WNL.0000000000000958","article-title":"Elevated rates of intracerebral hemorrhage in individuals from a US clinical care HIV cohort","volume":"83","author":"Chow","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jacbts.2021.10.017_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/QAI.0b013e31821d33a5","article-title":"Association between HIV infection, antiretroviral therapy, and risk of acute myocardial infarction: a cohort and nested case-control study using Quebec's public health insurance database","volume":"57","author":"Durand","year":"2011","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacbts.2021.10.017_bib12","article-title":"HIV infection and cardiovascular disease in women","volume":"3","author":"Womack","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2021.10.017_bib13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11886-016-0794-x","article-title":"Cardiovascular complications of HIV in endemic countries","volume":"18","author":"Feinstein","year":"2016","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jacbts.2021.10.017_bib14","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction","volume":"173","author":"Freiberg","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jacbts.2021.10.017_bib15","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/QAD.0b013e328339192f","article-title":"Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population","volume":"24","author":"Lang","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jacbts.2021.10.017_bib16","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1086\/518285","article-title":"Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study","volume":"44","author":"Obel","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/QAI.0000000000000419","article-title":"HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction","volume":"68","author":"Paisible","year":"2015","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacbts.2021.10.017_bib18","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1161\/CIRCULATIONAHA.113.004574","article-title":"Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research","volume":"129","author":"Remick","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.10.017_bib19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/jamacardio.2017.0264","article-title":"Association between HIV infection and the risk of heart failure with reduced ejection fraction and preserved ejection fraction in the antiretroviral therapy era: results from the Veterans Aging Cohort Study","volume":"2","author":"Freiberg","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib20","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1212\/WNL.0000000000001560","article-title":"HIV status and the risk of ischemic stroke among men","volume":"84","author":"Sico","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jacbts.2021.10.017_bib21","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1097\/QAD.0b013e3283493fb0","article-title":"Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study","volume":"25","author":"Rasmussen","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.jacbts.2021.10.017_bib22","article-title":"HIV Infection and incidence of cardiovascular diseases: an analysis of a large healthcare database","volume":"8","author":"Alonso","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2021.10.017_bib23","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1161\/CIRCULATIONAHA.109.865600","article-title":"Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease","volume":"120","author":"Diehm","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.10.017_bib24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0003319707302494","article-title":"The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients","volume":"58","author":"Poredos","year":"2007","journal-title":"Angiology"},{"key":"10.1016\/j.jacbts.2021.10.017_bib25","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.21037\/atm.2018.10.08","article-title":"Risk of peripheral artery disease in human immunodeficiency virus infected individuals","volume":"6","author":"Belgrave","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jacbts.2021.10.017_bib26","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1086\/527564","article-title":"High prevalence of peripheral arterial disease in HIV-infected persons","volume":"46","author":"Periard","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/CIRCULATIONAHA.117.032647","article-title":"Association of human immunodeficiency virus infection and risk of peripheral artery disease","volume":"138","author":"Beckman","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.10.017_bib28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1513\/pats.201006-046WR","article-title":"Pathogenesis of HIV-associated pulmonary hypertension: potential role of HIV-1 Nef","volume":"8","author":"Almodovar","year":"2011","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.jacbts.2021.10.017_bib29","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/COH.0000000000000418","article-title":"HIV-associated pulmonary hypertension","volume":"12","author":"Jarrett","year":"2017","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.jacbts.2021.10.017_bib30","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1016\/S2214-109X(17)30451-5","article-title":"Prevalence of chronic obstructive pulmonary disease in the global population with HIV: a systematic review and meta-analysis","volume":"6","author":"Bigna","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jacbts.2021.10.017_bib31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A\u00a0global view of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jacbts.2021.10.017_bib32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1086\/375844","article-title":"Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population","volume":"37","author":"Saves","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijcard.2016.05.027","article-title":"Heart failure in patients with human immunodeficiency virus infection: Epidemiology and management disparities","volume":"218","author":"Al-Kindi","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jacc.2016.11.013","article-title":"HIV Infection and heart failure outcomes in women","volume":"69","author":"Janjua","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11906-016-0689-7","article-title":"Pulmonary arterial hypertension and the sex hormone paradox","volume":"18","author":"Foderaro","year":"2016","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jacbts.2021.10.017_bib36","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.carrev.2019.05.026","article-title":"Peripheral arterial disease in women: the gender effect","volume":"21","author":"Patel","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jacbts.2021.10.017_bib37","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/hiv.12671","article-title":"Peripheral artery disease in HIV-infected older adults on antiretroviral treatment in Thailand","volume":"20","author":"Aurpibul","year":"2019","journal-title":"HIV Med"},{"key":"10.1016\/j.jacbts.2021.10.017_bib38","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-1293.2008.00602.x","article-title":"Effect of gender and highly active antiretroviral therapy on HIV-related pulmonary arterial hypertension: results of the HIV-HEART Study","volume":"9","author":"Reinsch","year":"2008","journal-title":"HIV Med"},{"key":"10.1016\/j.jacbts.2021.10.017_bib39","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/hiv.12261","article-title":"Pulmonary hypertension in HIV infection: a prospective echocardiographic study","volume":"16","author":"Schwarze-Zander","year":"2015","journal-title":"HIV Med"},{"key":"10.1016\/j.jacbts.2021.10.017_bib40","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.atherosclerosis.2006.12.022","article-title":"Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis","volume":"196","author":"Lorenz","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib41","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4330\/wjc.v7.i10.633","article-title":"Cardiovascular disease in human immunodeficiency virus infected patients: a true or perceived risk?","volume":"7","author":"Shahbaz","year":"2015","journal-title":"World J Cardiol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib42","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/S2352-3018(18)30295-9","article-title":"Contributions of traditional and HIV-related risk factors on non\u2013AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies","volume":"6","author":"Althoff","year":"2019","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jacbts.2021.10.017_bib43","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/QAD.0b013e32832b514b","article-title":"Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis","volume":"23","author":"Hsue","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jacbts.2021.10.017_bib44","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: testing and clinical relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.10.017_bib45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fcvm.2018.00185","article-title":"HIV Proteins and endothelial dysfunction: implications in cardiovascular disease","volume":"5","author":"Anand","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacbts.2021.10.017_bib46","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/febs.14657","article-title":"Vascular endothelial dysfunction in the wake of HIV and ART","volume":"286","author":"Marincowitz","year":"2019","journal-title":"FEBS J"},{"key":"10.1016\/j.jacbts.2021.10.017_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1590\/S1413-86702006000200012","article-title":"Endothelial function and cardiovascular diseases in HIV infected patient","volume":"10","author":"Andrade","year":"2006","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib48","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1161\/01.CIR.0000012543.55874.47","article-title":"Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study","volume":"105","author":"Gokce","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.10.017_bib49","doi-asserted-by":"crossref","first-page":"9759735","DOI":"10.1155\/2017\/9759735","article-title":"Markers and biomarkers of endothelium: when something is rotten in the state","volume":"2017","author":"Goncharov","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jacbts.2021.10.017_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1515\/CCLM.2000.013","article-title":"Markers of endothelial dysfunction","volume":"38","author":"Muller","year":"2000","journal-title":"Clin Chem Lab Med"},{"issue":"suppl 1","key":"10.1016\/j.jacbts.2021.10.017_bib51","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.3109\/1354750X.2011.587893","article-title":"Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?","volume":"16","author":"Paulus","year":"2011","journal-title":"Biomarkers"},{"key":"10.1016\/j.jacbts.2021.10.017_bib52","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijcard.2012.03.025","article-title":"Flow mediated dilation and carotid intima media thickness: clinical markers or just research tools?","volume":"163","author":"Tousoulis","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib53","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/eurheartj\/ehq150","article-title":"Imaging of coronary atherosclerosis by computed tomography","volume":"31","author":"Achenbach","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacbts.2021.10.017_bib54","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1161\/CIR.0000000000000695","article-title":"Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association","volume":"140","author":"Feinstein","year":"2019","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.jacbts.2021.10.017_bib55","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib56","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/heartjnl-2011-300747","article-title":"Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review","volume":"98","author":"Peters","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.jacbts.2021.10.017_bib57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12879-016-2158-y","article-title":"Cardiovascular risk and endothelial function in people living with HIV\/AIDS: design of the multi-site, longitudinal EndoAfrica study in the Western Cape Province of South Africa","volume":"17","author":"Strijdom","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib58","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/cid\/civ013","article-title":"Myocardial infarction among Danish HIV-infected individuals: population-attributable fractions associated with smoking","volume":"60","author":"Rasmussen","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147822","article-title":"Associations between tobacco, alcohol, and drug use with coronary artery plaque among HIV-infected and uninfected men in the Multicenter AIDS Cohort Study","volume":"11","author":"Kelly","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jacbts.2021.10.017_bib60","doi-asserted-by":"crossref","first-page":"301","DOI":"10.7326\/0003-4819-150-5-200903030-00006","article-title":"Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection","volume":"150","author":"Silverberg","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacbts.2021.10.017_bib61","doi-asserted-by":"crossref","first-page":"ofu076","DOI":"10.1093\/ofid\/ofu076","article-title":"Aspirin use for primary and secondary prevention in human immunodeficiency virus (HIV)\u2013infected and HIV-uninfected patients","volume":"1","author":"Suchindran","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib62","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCULATIONAHA.115.016080","article-title":"Proprotein convertase subtilisin\/kexin type 9 inhibition: a new therapeutic mechanism for reducing cardiovascular disease risk","volume":"132","author":"Bergeron","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.10.017_bib63","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.atherosclerosis.2008.10.012","article-title":"Human immunodeficiency virus per se exerts atherogenic effects","volume":"204","author":"Oliviero","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib64","first-page":"127","article-title":"Endothelial cell dysfunction in HIV infection","volume":"5","author":"Lafeuillade","year":"1992","journal-title":"J\u00a0Acquir Immune Defic Syndr (1988)"},{"key":"10.1016\/j.jacbts.2021.10.017_bib65","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/clin.1996.0151","article-title":"Abnormal levels of circulating adhesion molecules in HIV-1 infection with characteristic alterations in opportunistic infections","volume":"81","author":"Nordoy","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib66","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0923-2494(97)82482-0","article-title":"Circulating cell adhesion molecules in HIV1-infected patients as indicator markers for AIDS progression","volume":"148","author":"Galea","year":"1997","journal-title":"Res Immunol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib67","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection","volume":"203","author":"Sandler","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib68","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/infdis\/jir520","article-title":"Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients","volume":"204","author":"Burdo","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib69","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1468-1293.2010.00835.x","article-title":"Interleukin-6 and d-dimer levels are associated with vascular dysfunction in patients with untreated HIV infection","volume":"11","author":"Baker","year":"2010","journal-title":"HIV Med"},{"key":"10.1016\/j.jacbts.2021.10.017_bib70","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/cid\/cis406","article-title":"HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation","volume":"55","author":"Armah","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib71","article-title":"Inflammatory markers associated with subclinical coronary artery disease: the multicenter AIDS Cohort Study","volume":"5","author":"Bahrami","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2021.10.017_bib72","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/01.aids.0000171406.53737.f9","article-title":"Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure","volume":"19","author":"Currier","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.jacbts.2021.10.017_bib73","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/QAD.0b013e32811ebf79","article-title":"Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults","volume":"21","author":"Currier","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.jacbts.2021.10.017_bib74","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/01.CIR.0000124480.32233.8A","article-title":"Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection","volume":"109","author":"Hsue","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.10.017_bib75","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/QAD.0b013e32835eca9b","article-title":"Increased coronary atherosclerotic plaque vulnerability by coronary computed tomography angiography in HIV-infected men","volume":"27","author":"Zanni","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.jacbts.2021.10.017_bib76","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/QAD.0b013e328300581d","article-title":"Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men","volume":"22","author":"Kaplan","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jacbts.2021.10.017_bib77","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1097\/QAD.0b013e32835a9950","article-title":"Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers","volume":"26","author":"Pereyra","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.jacbts.2021.10.017_bib78","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1161\/ATVBAHA.119.312603","article-title":"Caspase-1 activation is related with HIV-associated atherosclerosis in an HIV transgenic mouse model and HIV patient cohort","volume":"39","author":"Kearns","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib79","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jneuroim.2016.01.022","article-title":"Characterization of neuropathology in the HIV-1 transgenic rat at different ages","volume":"292","author":"Reid","year":"2016","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fasebj.2020.34.s1.06242","article-title":"HIV increases basal metabolic rate, impairs endothelial function and elevates blood pressure in male and female mice","volume":"34","author":"Kress","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.jacbts.2021.10.017_bib81","doi-asserted-by":"crossref","first-page":"L315","DOI":"10.1152\/ajplung.00045.2011","article-title":"Human immunodeficiency virus transgenic rats exhibit pulmonary hypertension","volume":"301","author":"Lund","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib82","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.coviro.2016.07.012","article-title":"Non-human primate models of SIV infection and CNS neuropathology","volume":"19","author":"Williams","year":"2016","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib83","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s13365-018-0630-8","article-title":"Caspase-1\u2013associated immune activation in an accelerated SIV-infected rhesus macaque model","volume":"24","author":"Kearns","year":"2018","journal-title":"J\u00a0Neurovirol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib84","doi-asserted-by":"crossref","first-page":"H2792","DOI":"10.1152\/ajpheart.91447.2007","article-title":"Vascular oxidative stress and nitric oxide depletion in HIV-1 transgenic rats are reversed by glutathione restoration","volume":"294","author":"Kline","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib85","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1476-5381.2011.01249.x","article-title":"NOX1, 2, 4, 5: counting out oxidative stress","volume":"164","author":"Wingler","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib86","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1089\/ars.2005.7.1327","article-title":"NADPH oxidase-mediated oxidative stress: genetic studies of the p22(phox) gene in hypertension","volume":"7","author":"Zalba","year":"2005","journal-title":"Antiox Redox Signal"},{"key":"10.1016\/j.jacbts.2021.10.017_bib87","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1471-4159.2003.01543.x","article-title":"HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium","volume":"84","author":"Toborek","year":"2003","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.jacbts.2021.10.017_bib88","doi-asserted-by":"crossref","first-page":"11710","DOI":"10.1128\/JVI.76.22.11710-11714.2002","article-title":"Elevated levels of tumor necrosis factor alpha (TNF-alpha) in human immunodeficiency virus type 1-transgenic mice: prevention of death by antibody to TNF-alpha","volume":"76","author":"De","year":"2002","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib89","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1089\/aid.2013.0280","article-title":"Microbial translocation and cardiometabolic risk factors in HIV infection","volume":"30","author":"Troseid","year":"2014","journal-title":"AIDS Res Hum Retrov"},{"key":"10.1016\/j.jacbts.2021.10.017_bib90","article-title":"CCR5 inhibition prevents cardiac dysfunction in the SIV\/macaque model of HIV","volume":"3","author":"Kelly","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2021.10.017_bib91","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006866","article-title":"HIV: cell binding and entry","volume":"2","author":"Wilen","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.jacbts.2021.10.017_bib92","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax0821","article-title":"Targeting CCR5 trafficking to inhibit HIV-1 infection","volume":"5","author":"Boncompain","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.jacbts.2021.10.017_bib93","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijid.2020.10.101","article-title":"CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14","volume":"103","author":"Patterson","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib94","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1161\/CIRCULATIONAHA.113.001278","article-title":"Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice","volume":"127","author":"Cipriani","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.10.017_bib95","article-title":"HIV protease inhibitor ritonavir impairs endothelial function via reduction in adipose mass and endothelial leptin receptor-dependent increases in NADPH oxidase 1 (Nox1), C-C chemokine receptor type 5 (CCR5), and inflammation","volume":"9","author":"Bruder-Nascimento","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacbts.2021.10.017_bib96","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1124\/mol.106.025973","article-title":"HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein","volume":"70","author":"Ronaldson","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib97","doi-asserted-by":"crossref","first-page":"6700","DOI":"10.1128\/JVI.77.12.6700-6708.2003","article-title":"Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism","volume":"77","author":"Yang","year":"2003","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib98","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.4049\/jimmunol.170.4.1716","article-title":"HIV-1 Nef induces the release of inflammatory factors from human monocyte\/macrophages: involvement of Nef endocytotic signals and NF-kappa B activation","volume":"170","author":"Olivetta","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib99","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1182\/blood-2003-08-2928","article-title":"Migration of V delta 1 and V delta 2\u00a0T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat","volume":"103","author":"Poggi","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jacbts.2021.10.017_bib100","doi-asserted-by":"crossref","first-page":"11466","DOI":"10.1073\/pnas.97.21.11466","article-title":"Selective CXCR4 antagonism by Tat: implications for in\u00a0vivo expansion of coreceptor use by HIV-1","volume":"97","author":"Xiao","year":"2000","journal-title":"Proc of Natl Acad Sci U S A"},{"key":"10.1016\/j.jacbts.2021.10.017_bib101","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/01.ATV.17.8.1517","article-title":"Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice","volume":"17","author":"Nageh","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib102","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0165-2478(96)02556-4","article-title":"Immunological and virological studies of natural SIV infection of disease-resistant nonhuman primates","volume":"51","author":"Villinger","year":"1996","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jacbts.2021.10.017_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008170","article-title":"Regional gene expression of LOX-1, VCAM-1, and ICAM-1 in aorta of HIV-1 transgenic rats","volume":"4","author":"Hag","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jacbts.2021.10.017_bib104","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/labinvest.3780418","article-title":"HIV-1 envelope glycoprotein 120 increases intercellular adhesion molecule-1 expression by human endothelial cells","volume":"82","author":"Ren","year":"2002","journal-title":"Lab Invest"},{"key":"10.1016\/j.jacbts.2021.10.017_bib105","article-title":"HIV Tat induces expression of ICAM-1 in HUVECs: implications for miR-221\/-222 in HIV-associated cardiomyopathy","volume":"8","author":"Duan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jacbts.2021.10.017_bib106","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/0003319710364215","article-title":"The role of ERK1\/2 signaling pathway in Nef protein upregulation of the expression of the intercellular adhesion molecule 1 in endothelial cells","volume":"61","author":"Fan","year":"2010","journal-title":"Angiology"},{"key":"10.1016\/j.jacbts.2021.10.017_bib107","doi-asserted-by":"crossref","first-page":"L252","DOI":"10.1152\/ajplung.00200.2004","article-title":"HIV-1 Tat protein-induced VCAM-1 expression in human pulmonary artery endothelial cells and its signaling","volume":"289","author":"Liu","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib108","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/qjmed\/hcg145","article-title":"Endothelial function in HIV-infected patients receiving protease inhibitor therapy: does immune competence affect cardiovascular risk?","volume":"96","author":"Nolan","year":"2003","journal-title":"QJM"},{"key":"10.1016\/j.jacbts.2021.10.017_bib109","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12012-007-9010-y","article-title":"Severe impairment of endothelial function with the HIV-1 protease inhibitor indinavir is not mediated by insulin resistance in healthy subjects","volume":"8","author":"Dube","year":"2008","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/01.CIR.104.3.257","article-title":"Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction","volume":"104","author":"Stein","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.10.017_bib111","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCULATIONAHA.104.517144","article-title":"Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy","volume":"112","author":"Charakida","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacbts.2021.10.017_bib112","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1086\/503261","article-title":"Endothelial function in HIV-infected persons","volume":"42","author":"Solages","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib113","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0021-9150(01)00736-5","article-title":"Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors","volume":"162","author":"Seminari","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib114","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1161\/01.ATV.0000183744.38509.de","article-title":"Impact of treatment with protease inhibitors on aortic stiffness in adult patients with human immunodeficiency virus infection","volume":"25","author":"Schillaci","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib115","doi-asserted-by":"crossref","first-page":"F123","DOI":"10.1097\/00002030-200011100-00001","article-title":"Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors","volume":"14","author":"Maggi","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.jacbts.2021.10.017_bib116","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00126334-200304150-00004","article-title":"Brief report: carotid intima-media thickness in heavily pretreated HIV-infected patients","volume":"32","author":"Chironi","year":"2003","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacbts.2021.10.017_bib117","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/aid.2006.0281","article-title":"Cross-sectional study of endothelial function in HIV-infected patients in Brazil","volume":"24","author":"Andrade","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.jacbts.2021.10.017_bib118","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1097\/QAD.0b013e32832e7140","article-title":"Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients","volume":"23","author":"Hsue","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jacbts.2021.10.017_bib119","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00259-008-0846-6","article-title":"Coronary and peripheral endothelial function in HIV patients studied with positron emission tomography and flow-mediated dilation: relation to hypercholesterolemia","volume":"35","author":"Lebech","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jacbts.2021.10.017_bib120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183511","article-title":"HIV infection, antiretroviral therapy, and measures of endothelial function, inflammation, metabolism, and oxidative stress","volume":"12","author":"Dysangco","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jacbts.2021.10.017_bib121","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacc.2008.04.049","article-title":"Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: the ACTG (AIDS Clinical Trials Group) study 5152s","volume":"52","author":"Torriani","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1293.2012.01027.x","article-title":"Endothelial dysfunction, increased inflammation, and activated coagulation in HIV-infected patients improve after initiation of highly active antiretroviral therapy","volume":"14","author":"Arildsen","year":"2013","journal-title":"HIV Med"},{"key":"10.1016\/j.jacbts.2021.10.017_bib123","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/078538902317338652","article-title":"Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement","volume":"34","author":"Mercie","year":"2002","journal-title":"Ann Med"},{"key":"10.1016\/j.jacbts.2021.10.017_bib124","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1086\/597475","article-title":"Increase in carotid artery intima-media thickness and arterial stiffness but improvement in several markers of endothelial function after initiation of antiretroviral therapy","volume":"199","author":"van Vonderen","year":"2009","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib125","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/ajh.2009.90","article-title":"Association of highly active antiretroviral therapy with increased arterial stiffness in patients infected with human immunodeficiency virus","volume":"22","author":"Lekakis","year":"2009","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacbts.2021.10.017_bib126","doi-asserted-by":"crossref","first-page":"458","DOI":"10.7326\/M13-1754","article-title":"Associations between HIV infection and subclinical coronary atherosclerosis","volume":"160","author":"Post","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacbts.2021.10.017_bib127","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.atherosclerosis.2015.03.015","article-title":"Endothelial activation and cardiometabolic profiles of treated and never-treated HIV infected Africans","volume":"240","author":"Fourie","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib128","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5830\/CVJA-2018-003","article-title":"HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana","volume":"29","author":"Mosepele","year":"2018","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.jacbts.2021.10.017_bib129","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/QAI.0000000000001074","article-title":"D-Dimer levels and traditional risk factors are associated with incident hypertension among HIV-infected individuals initiating antiretroviral therapy in Uganda","volume":"73","author":"Okello","year":"2016","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacbts.2021.10.017_bib130","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/QAD.0b013e32832995fa","article-title":"HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial","volume":"23","author":"Calmy","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jacbts.2021.10.017_bib131","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/QAI.0b013e318189a794","article-title":"Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and lipoatrophy","volume":"49","author":"Ross","year":"2008","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacbts.2021.10.017_bib132","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/QAD.0b013e328354f4fb","article-title":"Inflammation markers after randomization to abacavir\/lamivudine or tenofovir\/emtricitabine with efavirenz or atazanavir\/ritonavir","volume":"26","author":"McComsey","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.jacbts.2021.10.017_bib133","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1468-1293.2008.00661.x","article-title":"Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy","volume":"10","author":"Kristoffersen","year":"2009","journal-title":"HIV Med"},{"key":"10.1016\/j.jacbts.2021.10.017_bib134","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/QAD.0b013e328325a87c","article-title":"HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction","volume":"23","author":"Francisci","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jacbts.2021.10.017_bib135","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/QAI.0b013e31819a292c","article-title":"Plasma levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controls","volume":"50","author":"Calza","year":"2009","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacbts.2021.10.017_bib136","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/COH.0000000000000019","article-title":"Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients","volume":"9","author":"Funderburg","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.jacbts.2021.10.017_bib137","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1086\/338572","article-title":"Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1","volume":"185","author":"Wolf","year":"2002","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib138","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/QAI.0b013e3181f7f61a","article-title":"Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection","volume":"56","author":"Baker","year":"2011","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacbts.2021.10.017_bib139","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/infdis\/jir214","article-title":"Soluble CD163 made by monocyte\/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy","volume":"204","author":"Burdo","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib140","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/QAD.0b013e3283352ed5","article-title":"Change to atazanavir\/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy","volume":"24","author":"Murphy","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jacbts.2021.10.017_bib141","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1086\/590154","article-title":"No impairment of endothelial function or insulin sensitivity with 4\u00a0weeks of the HIV protease inhibitors atazanavir or lopinavir-ritonavir in healthy subjects without HIV infection: a placebo-controlled trial","volume":"47","author":"Dube","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib142","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3851\/IMP2752","article-title":"Impact of darunavir, atazanavir and lopinavir boosted with ritonavir on cultured human endothelial cells: beneficial effect of pravastatin","volume":"19","author":"Auclair","year":"2014","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jacbts.2021.10.017_bib143","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A\u00a0syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.jacbts.2021.10.017_bib144","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00042560-200201010-00004","article-title":"Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy","volume":"29","author":"Estrada","year":"2002","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacbts.2021.10.017_bib145","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/367859","article-title":"Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin","volume":"36","author":"Nagy","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib146","first-page":"201027","article-title":"Hypertriglyceridemia, metabolic syndrome, and cardiovascular disease in HIV-infected patients: effects of antiretroviral therapy and adipose tissue distribution","volume":"2012","author":"van Wijk","year":"2012","journal-title":"Int J Vasc Med"},{"key":"10.1016\/j.jacbts.2021.10.017_bib147","article-title":"Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women","volume":"8","author":"Martin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jacbts.2021.10.017_bib148","doi-asserted-by":"crossref","first-page":"ofu117","DOI":"10.1093\/ofid\/ofu117","article-title":"Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographics","volume":"2","author":"Li","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib149","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/ATVBAHA.113.303153","article-title":"Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with human immunodeficiency virus or hepatitis C virus infection","volume":"34","author":"Shaked","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib150","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/infdis\/jit508","article-title":"Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women","volume":"208","author":"Fitch","year":"2013","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib151","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.4049\/jimmunol.180.4.2029","article-title":"Cutting edge: progesterone regulates IFN-alpha production by plasmacytoid dendritic cells","volume":"180","author":"Hughes","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib152","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.4049\/jimmunol.1501684","article-title":"Sex differences in plasmacytoid dendritic cell levels of IRF5 drive higher IFN-alpha production in women","volume":"195","author":"Griesbeck","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jacbts.2021.10.017_bib153","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/nm.2004","article-title":"Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1","volume":"15","author":"Meier","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.jacbts.2021.10.017_bib154","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00126334-200304010-00017","article-title":"Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisited","volume":"32","author":"Moore","year":"2003","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacbts.2021.10.017_bib155","doi-asserted-by":"crossref","first-page":"ofw047","DOI":"10.1093\/ofid\/ofw047","article-title":"Influence of sex\/gender and race on responses to raltegravir combined with tenofovir-emtricitabine in treatment-naive human immunodeficiency virus-1 infected patients: pooled analyses of the STARTMRK and QDMRK studies","volume":"4","author":"Squires","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jacbts.2021.10.017_bib156","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/QAI.0000000000001095","article-title":"Sex-related differences in inflammatory and immune activation markers before and after combined antiretroviral therapy initiation","volume":"73","author":"Mathad","year":"2016","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacbts.2021.10.017_bib157","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1097\/QAD.0000000000000758","article-title":"Biomarkers of inflammation in HIV-infected Peruvian men and women before and during suppressive antiretroviral therapy","volume":"29","author":"Ticona","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.jacbts.2021.10.017_bib158","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1212\/WNL.0000000000000237","article-title":"A\u00a0decade of racial and ethnic stroke disparities in the United States","volume":"82","author":"Gutierrez","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jacbts.2021.10.017_bib159","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/QAD.0000000000001799","article-title":"Stroke incidence is highest in women and non-Hispanic blacks living with HIV in the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials cohort","volume":"32","author":"Chow","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.jacbts.2021.10.017_bib160","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1080\/09540121.2015.1046416","article-title":"Barriers to access to care reported by women living with HIV across 27 countries","volume":"27","author":"Johnson","year":"2015","journal-title":"AIDS Care"},{"key":"10.1016\/j.jacbts.2021.10.017_bib161","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/QAI.0000000000001279","article-title":"Sex differences in tobacco use among persons living with HIV\/AIDS: a systematic review and meta-analysis","volume":"74","author":"Weinberger","year":"2017","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jacbts.2021.10.017_bib162","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/08964289.2013.866540","article-title":"Substance abuse treatment in persons with HIV\/AIDS: challenges in managing triple diagnosis","volume":"40","author":"Durvasula","year":"2014","journal-title":"Behav Med"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X21003582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X21003582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:24:41Z","timestamp":1762820681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X21003582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":161,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2452302X21003582"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2021.10.017","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV, Combination Antiretroviral Therapy, and Vascular Diseases in Men and Women","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2021.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}